Cargando…
Can RNAi-mediated hsp90α knockdown in combination with 17-AAG be a therapy for glioma?()
Heat shock protein 90 promotes tumor progression and survival and has emerged as a vital therapeutic target. Previously we reported that the combinatorial treatment of 17AAG/sihsp90α significantly downregulated Hsp90α mRNA and protein levels in Glioblastoma Multiforme (GBM). Here we investigated the...
Autores principales: | Mehta, Adi, Shervington, Amal, Howl, John, Jones, Sarah, Shervington, Leroy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3722647/ https://www.ncbi.nlm.nih.gov/pubmed/23905009 http://dx.doi.org/10.1016/j.fob.2013.06.002 |
Ejemplares similares
-
A Novel Therapeutic Strategy for the Treatment of Glioma, Combining Chemical and Molecular Targeting of Hsp90α
por: Mehta, Adi, et al.
Publicado: (2011) -
Could the Anti-Chaperone VER155008 Replace Temozolomide for Glioma Treatment
por: Shervington, Leroy, et al.
Publicado: (2015) -
A novel series of phenolic temozolomide (TMZ) esters with 4 to 5-fold increased potency, compared to TMZ, against glioma cells irrespective of MGMT expression
por: Shervington, Leroy, et al.
Publicado: (2020) -
Identifying Reliable Diagnostic/Predictive Biomarkers for Rheumatoid
Arthritis
por: Shervington, Leroy, et al.
Publicado: (2018) -
Can CYP1A1 siRNA be an effective treatment for lung cancer?
por: Mohammed, Kulthum, et al.
Publicado: (2008)